The modulating effects of vitamin D on the activity of β-catenin in the endometrium of women with endometriosis: a randomized exploratory trial.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc in the context of endometriosis, published as a randomized controlled trial.

The aim of this prospective study was to investigate the effects of vitamin D on the expression and activity of β-catenin, as the key molecule of the Wnt/β-catenin signaling pathway, in endometriosis women.

Who Took Part

The age groups tagged for this paper are adults, women only.

Thirty four infertile women with stage III or IV endometriosis were randomly divided to two groups.

How the Study Was Run

The design is described as randomized and pilot.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.

Blood and endometrial tissue were collected from both groups before and after the intervention.

Protein and Gene expression levels of β-catenin were assessed by Western blotting and Real-Time PCR, respectively.

What Was Measured

Topics PubMed links to this paper include Case-Control Studies, Endometriosis, Endometrium, Infertility, Female, Iran, Pilot Projects and Uterine Diseases.

Author keywords: vitamin D and β-catenin.

What This Means in Plain Language

The paper is a randomized and pilot study of Vitamin D, K2, Magnesium and Zinc in people with endometriosis.

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2021 (Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, Endometriosis research.